« Back
Home /
AZD1208

AZD1208

Item no.	TMO-T2300-200mg
Manufacturer	TargetMol
CASRN	1204144-28-4
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category	Oncology Reagents & Chemicals Molecules By Organ Bone Cancer
Type	Molecules
Specific against	other
Citations	1. Kirschner AN, et al. J Natl Y Inst. 2014 Dec 13;107(2) 2. Keeton EK, et al. Blood. 2014 Feb 6;123(6):905-13..
Smiles	NC1CCCN(C1)c1c(\C=C2/SC(=O)NC2=O)cccc1-c1ccccc1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Pim inhibitor
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Apoptosis\|\|\|Pim\|\|\|Autophagy
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	379.48
Description	AZD1208 is a novel, orally bioavailable, highly selective PIM kinase inhibitor with single nanomolar potency against all three PIM kinases.
Pathways	Autophagy\|\|\|Chromatin/Epigenetic\|\|\|Apoptosis\|\|\|JAK/STAT signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T2300-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question